The Impact of chemo brain on the patient with a high-grade glioma

Advances in Experimental Medicine and Biology

Volumn 678, Issue , 2010, Pages 21-25

  Lucas, Michele R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CAREGIVER BURDEN; CHEMO BRAIN; COGNITIVE DEFECT; FAMILY STRESS; GLIOMA; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL SECURITY; SOCIETY; CHEMICALLY INDUCED DISORDER; DRUG THERAPY; FAMILY; PATHOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL CHANGE;

ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; DRUG THERAPY; FAMILY; GLIOMA; HUMANS; QUALITY OF LIFE; SOCIAL CHANGE;

EID: 77956646449     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6306-2_5     Document Type: Article

References (16)

1. Correa DD, Ahles TA. Neurocognitive changes in cancer patients. Cancer J 2008; 14(6):396-400.
2. Dietrich Jorg, Monte M, Wefel J et al. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 2008; 13:1-11.
3. Fox S, Lantz C. The brain tumor experience and quality of life: a qualitative study. J Neurosci Nurs 1998; 30:245-255.
4. Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 2007; 39(1):61-67.
5. Hahn CA, Dunn RH, Logue PE et al. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 2003; 55(4):992-999. (Pubitemid 36287002)
6. Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 2007; 34(5):981-994.
7. Kayl AE, Wefel JS, Meyers CA. Chemotherapy and cognition: Effects, potential mechanisms and management. Am J Ther 2006; 13:362-369. (Pubitemid 44492257)
8. Kipnis J, Derecki NC, Yang C et al. Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Cell 2008; 455-463.
9. Mauer ME, Bottomley A, Taphoon MJB. Evaluating health-related quality of life and symptom burden in brain tumor patients: instruments for use in experimental trials and clinical practice. Curr Opin in Neurol 2008; 21:745-753.
10. Munoz C, Juarez G, Munoz M et al. The quality of life of patients with malignant gliomas and their caregivers. Soc Work Health Care 2008; 47(4):455-478.
11. Raffa RB, Duong PV, Finney J et al. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? J Clin Pharm Ther 2006; 31:129-138.
12. Remer S, Murphy ME. The challenges of long-term treatment outcomes in adults with malignant gliomas. Clin J Oncol Nurs 2004; 8(4):368-376.
13. Staat K, Segatore M. The phenomenon of chemo brain. Clin J Oncol Nurs 2005; 9(6):713-721.
14. Taphoon MJB, Klein M. Cognitive deficits in adult patients with brain tumors. Lancet Neurol 2004; 3:159-168. (Pubitemid 38229950)
15. Wefel JS, Lenzi R, Theriault RL et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. American Cancer Society; 2004; online: 2292-2299.
16. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psycho-oncology 1997; 6:169-177. (Pubitemid 27400533)